81 results on '"Aldape, Kenneth"'
Search Results
2. Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse
3. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors
4. Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype
5. Pseudoendocrine sarcoma: clinicopathologic, molecular, and epigenetic features of one case
6. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
7. Germline findings in cancer predisposing genes from a small cohort of chordoma patients
8. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities
9. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature
10. Estimation of cell lineages in tumors from spatial transcriptomics data
11. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
12. Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes
13. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
14. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
15. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
16. The multiomic landscape of meningiomas: a review and update
17. Molecular classification and grading of meningioma
18. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1
19. Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions
20. Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases
21. Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion
22. Potential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor
23. Big data in basic and translational cancer research
24. Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases
25. The role of methylation profiling in histologically diagnosed neurocytoma: a case series
26. Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
27. Recurrent ACVR1 mutations in posterior fossa ependymoma
28. A T cell resilience model associated with response to immunotherapy in multiple tumor types
29. Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology
30. Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes
31. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13
32. DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival
33. Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma
34. A clinically applicable integrative molecular classification of meningiomas
35. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
36. A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations
37. Epigenomic, genomic, and transcriptomic landscape of schwannomatosis
38. Immune cell deconvolution of bulk DNA methylation data reveals an association with methylation class, key somatic alterations, and cell state in glial/glioneuronal tumors
39. TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy
40. Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor types
41. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation
42. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
43. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
44. Longitudinal molecular trajectories of diffuse glioma in adults
45. Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
46. Challenges to curing primary brain tumours
47. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
48. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
49. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
50. Heterogeneity within the PF-EPN-B ependymoma subgroup
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.